265 related articles for article (PubMed ID: 32147571)
1. A randomized placebo-controlled trial of bupropion for Cancer-related fatigue: Study design and procedures.
Jim HSL; Hoogland AI; Han HS; Culakova E; Heckler C; Janelsins M; Williams GC; Bower J; Cole S; Desta Z; Babilonia MB; Morrow G; Peppone L
Contemp Clin Trials; 2020 Apr; 91():105976. PubMed ID: 32147571
[TBL] [Abstract][Full Text] [Related]
2. Potential Role of Bupropion Sustained Release for Cancer-Related Fatigue: a Double-Blind, Placebo-Controlled Study.
Ashrafi F; Mousavi S; Karimi M
Asian Pac J Cancer Prev; 2018 Jun; 19(6):1547-1551. PubMed ID: 29936730
[TBL] [Abstract][Full Text] [Related]
3. Eight-week, placebo-controlled, double-blind comparison of the antidepressant efficacy and tolerability of bupropion XR and venlafaxine XR.
Hewett K; Chrzanowski W; Schmitz M; Savela A; Milanova V; Gee M; Krishen A; Millen L; Leary MO; Modell J
J Psychopharmacol; 2009 Jul; 23(5):531-8. PubMed ID: 18635695
[TBL] [Abstract][Full Text] [Related]
4. Efficacy and safety of bupropion in cancer-related fatigue, a randomized double blind placebo controlled clinical trial.
Salehifar E; Azimi S; Janbabai G; Zaboli E; Hendouei N; Saghafi F; Borhani S
BMC Cancer; 2020 Feb; 20(1):158. PubMed ID: 32106832
[TBL] [Abstract][Full Text] [Related]
5. Extended-release bupropion for patients with major depressive disorder presenting with symptoms of reduced energy, pleasure, and interest: findings from a randomized, double-blind, placebo-controlled study.
Jefferson JW; Rush AJ; Nelson JC; VanMeter SA; Krishen A; Hampton KD; Wightman DS; Modell JG
J Clin Psychiatry; 2006 Jun; 67(6):865-73. PubMed ID: 16848645
[TBL] [Abstract][Full Text] [Related]
6. Bupropion for the Treatment of Apathy in Alzheimer Disease: A Randomized Clinical Trial.
Maier F; Spottke A; Bach JP; Bartels C; Buerger K; Dodel R; Fellgiebel A; Fliessbach K; Frölich L; Hausner L; Hellmich M; Klöppel S; Klostermann A; Kornhuber J; Laske C; Peters O; Priller J; Richter-Schmidinger T; Schneider A; Shah-Hosseini K; Teipel S; von Arnim CAF; Wiltfang J; Jessen F
JAMA Netw Open; 2020 May; 3(5):e206027. PubMed ID: 32463470
[TBL] [Abstract][Full Text] [Related]
7. An open-label study of the effects of bupropion SR on fatigue, depression and quality of life of mixed-site cancer patients and their partners.
Moss EL; Simpson JS; Pelletier G; Forsyth P
Psychooncology; 2006 Mar; 15(3):259-67. PubMed ID: 16041840
[TBL] [Abstract][Full Text] [Related]
8. Bupropion sustained release added to group support for smoking cessation in schizophrenia: a new randomized trial and a meta-analysis.
Weiner E; Ball MP; Buchholz AS; Gold JM; Evins AE; McMahon RP; Buchanan RW
J Clin Psychiatry; 2012 Jan; 73(1):95-102. PubMed ID: 21535998
[TBL] [Abstract][Full Text] [Related]
9. Bupropion for control of hot flashes in breast cancer survivors: a prospective, double-blind, randomized, crossover, pilot phase II trial.
Nuñez GR; Pinczowski H; Zanellato R; Tateyama L; Schindler F; Fonseca F; Del Giglio A
J Pain Symptom Manage; 2013 Jun; 45(6):969-79. PubMed ID: 23017618
[TBL] [Abstract][Full Text] [Related]
10. A multicenter evaluation of the efficacy and safety of 150 and 300 mg/d sustained-release bupropion tablets versus placebo in depressed outpatients.
Reimherr FW; Cunningham LA; Batey SR; Johnston JA; Ascher JA
Clin Ther; 1998; 20(3):505-16. PubMed ID: 9663366
[TBL] [Abstract][Full Text] [Related]
11. A 12-week double-blind, placebo-controlled study of bupropion sr added to high-dose dual nicotine replacement therapy for smoking cessation or reduction in schizophrenia.
Evins AE; Cather C; Culhane MA; Birnbaum A; Horowitz J; Hsieh E; Freudenreich O; Henderson DC; Schoenfeld DA; Rigotti NA; Goff DC
J Clin Psychopharmacol; 2007 Aug; 27(4):380-6. PubMed ID: 17632223
[TBL] [Abstract][Full Text] [Related]
12. Bupropion sustained release: a therapeutic overview.
Davidson JR; Connor KM
J Clin Psychiatry; 1998; 59 Suppl 4():25-31. PubMed ID: 9554318
[TBL] [Abstract][Full Text] [Related]
13. Bupropion sustained release treatment reduces fatigue in cancer patients.
Cullum JL; Wojciechowski AE; Pelletier G; Simpson JS
Can J Psychiatry; 2004 Feb; 49(2):139-44. PubMed ID: 15065748
[TBL] [Abstract][Full Text] [Related]
14. Melatonin Supplementation for Cancer-Related Fatigue in Patients With Early Stage Breast Cancer Receiving Radiotherapy: A Double-Blind Placebo-Controlled Trial.
Mukhopadhyay ND; Khorasanchi A; Pandey S; Nemani S; Parker G; Deng X; Arthur DW; Urdaneta A; Del Fabbro E
Oncologist; 2024 Feb; 29(2):e206-e212. PubMed ID: 37699115
[TBL] [Abstract][Full Text] [Related]
15. Efficacy of sustained-release bupropion in neuropathic pain: an open-label study.
Semenchuk MR; Davis B
Clin J Pain; 2000 Mar; 16(1):6-11. PubMed ID: 10741812
[TBL] [Abstract][Full Text] [Related]
16. Sustained-release bupropion for selective serotonin reuptake inhibitor-induced sexual dysfunction: a randomized, double-blind, placebo-controlled, parallel-group study.
Masand PS; Ashton AK; Gupta S; Frank B
Am J Psychiatry; 2001 May; 158(5):805-7. PubMed ID: 11329407
[TBL] [Abstract][Full Text] [Related]
17. A placebo-controlled comparison of the effects on sexual functioning of bupropion sustained release and fluoxetine.
Coleman CC; King BR; Bolden-Watson C; Book MJ; Segraves RT; Richard N; Ascher J; Batey S; Jamerson B; Metz A
Clin Ther; 2001 Jul; 23(7):1040-58. PubMed ID: 11519769
[TBL] [Abstract][Full Text] [Related]
18. A placebo-controlled, randomized, double-blind study of adjunctive bupropion sustained release in the treatment of SSRI-induced sexual dysfunction.
DeBattista C; Solvason B; Poirier J; Kendrick E; Loraas E
J Clin Psychiatry; 2005 Jul; 66(7):844-8. PubMed ID: 16013899
[TBL] [Abstract][Full Text] [Related]
19. Bupropion and restless legs syndrome: a randomized controlled trial.
Bayard M; Bailey B; Acharya D; Ambreen F; Duggal S; Kaur T; Rahman ZU; Roller K; Tudiver F
J Am Board Fam Med; 2011; 24(4):422-8. PubMed ID: 21737767
[TBL] [Abstract][Full Text] [Related]
20. Evaluation of sexual functioning in depressed outpatients: a double-blind comparison of sustained-release bupropion and sertraline treatment.
Segraves RT; Kavoussi R; Hughes AR; Batey SR; Johnston JA; Donahue R; Ascher JA
J Clin Psychopharmacol; 2000 Apr; 20(2):122-8. PubMed ID: 10770448
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
